SUFU WM 2015 - Pelvic organ prolapse/reconstruction moderated podium - Session Highlights

SCOTTSDALE, AZ USA ( - Drs. Elise De and Donna Deng moderated the podium session for Pelvic Organ Prolapse/Reconstruction. Notable presentations were:

sufu#21: Prolapse recurrence after transvaginal mesh removal (Presented by Tanner Rawlings).
Mr. Rawlings presented the results of a prospective study from the University of Texas – Southwestern assessing prolapse recurrence after transvaginal pelvic organ prolapse (POP) mesh removal. Their mesh excision technique is to remove all mesh that can be safely removed. Recurrent prolapse was defined as greater than stage 1 prolapse or need for reoperation at the site of prior mesh removal. The mean duration from mesh implantation to removal for mesh-related complication was 45 months. The most common indication for mesh removal was dyspareunia (44%). At a mean follow up of 29 months, 8 patients (17%) had recurrent POP. Ultimately, 6 (12%) patients underwent surgery for their recurrent POP at a mean of 15 months postoperatively. No patient had recurrent rectocele.

#25: Outcome of direct visual internal urethrotomy (DVIU) for post-urethroplasty strictures (Presented by Stephen Mock, MD).
Dr. Mock presented the results of a retrospective review of 14 years of urethroplasty at Vanderbilt. Success of the DVIU was defined at lack of patient symptomatology and need for treatment interventions. Post-urethroplasty strictures occurred in 16% of 401 patients. Median stricture length was 4 cm. Seventy-three percent of patients underwent an endoscopic treatment and 27% underwent repeat urethroplasty. DVIU was not offered to patients with pinpoint strictures, long strictures, or dense strictures. DVIU was successful in 35% of cases. Repeat DVIU was successful in 67% of patients. Overall DVIU success was 46%. Treatment success did not differ by age, stricture length, time between urethroplasty and DVIU, etiology, stricture location, or urethroplasty type. The authors conclude that DVIU may be offered as a minimally-invasive option for the management of post-urethroplasty stricture.

Moderated by Elise J.B. De, MD and Donna Y. Deng, MD at the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) Winter Meeting - February 24 - 28, 2015 - JW Marriott Camelback Inn Resort & Spa - Scottsdale, AZ USA

sufu freilich squareReported for UroToday by Drew Freilich, MD. Dr. Freilich is a graduate of the University of Massachusetts Medical School and completed his urology residency at New York Medical College/Westchester Medical Center. He is currently a fellow in Female Urology, Neurourology and Reconstructive Urology at Medical University of South Carolina. He has authored more than 40 peer-reviewed articles, monographs, abstracts, and book chapters and abstracts. Dr. Freilich is a member of the American Urological Association and the Society for Urodynamics and Female Urology.



SUFU MyBladder app